Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders

Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies. Am J Pathol 152:879–884

CAS  PubMed  PubMed Central  Google Scholar 

Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proc Natl Acad Sci 95:6469–6473. https://doi.org/10.1073/pnas.95.11.6469

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous a-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies. Neurosci Lett 4

Hishikawa N, Hashizume Y, Yoshida M, Sobue G (2001) Widespread occurrence of argyrophilic glial inclusions in Parkinson’s disease. Neuropathol Appl Neurobiol 27:362–372. https://doi.org/10.1046/j.1365-2990.2001.00345.x

Article  CAS  PubMed  Google Scholar 

Shoji M, Harigaya Y, Sasaki A, Ueda K, Ishiguro K, Matsubara E, Watanabe M, Ikeda M, Kanai M, Tomidokoro Y, Shizuka M, Amari M, Kosaka K, Nakazato Y, Okamoto K, Hirai S (2000) Accumulation of NACP/alpha -synuclein in Lewy body disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 68:605–608. https://doi.org/10.1136/jnnp.68.5.605

Article  CAS  PubMed  PubMed Central  Google Scholar 

Takeda A, Hashimoto M, Mallory M, Sundsumo M, Hansen L, Masliah E (2000) C-terminal α-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders. Acta Neuropathol 99:296–304. https://doi.org/10.1007/PL00007441

Article  CAS  PubMed  Google Scholar 

Terada S, Ishizu H, Yokota O, Tsuchiya K, Nakashima H, Ishihara T, Fujita D, Uéda K, Ikeda K, Kuroda S (2003) Glial involvement in diffuse Lewy body disease. Acta Neuropathol 105:163–169. https://doi.org/10.1007/s00401-002-0622-9

Article  CAS  PubMed  Google Scholar 

Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H (2000) NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains. Acta Neuropathol 99:14–20. https://doi.org/10.1007/PL00007400

Article  CAS  PubMed  Google Scholar 

Braak H, Sastre M, Del Tredici K (2007) Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson’s disease. Acta Neuropathol 114:231–241. https://doi.org/10.1007/s00401-007-0244-3

Article  CAS  PubMed  Google Scholar 

Fathy YY, Jonker AJ, Oudejans E, Jong FJJ, Dam A-MW, Rozemuller AJM, Berg WDJ (2019) Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson’s disease and dementia with Lewy bodies. Neuropathol Appl Neurobiol 45:262–277. https://doi.org/10.1111/nan.12501

Article  CAS  PubMed  Google Scholar 

Kovacs GG, Breydo L, Green R, Kis V, Puska G, Lőrincz P, Perju-Dumbrava L, Giera R, Pirker W, Lutz M, Lachmann I, Budka H, Uversky VN, Molnár K, László L (2014) Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread. Neurobiol Dis 69:76–92. https://doi.org/10.1016/j.nbd.2014.05.020

Article  CAS  PubMed  Google Scholar 

Kovacs GG, Wagner U, Dumont B, Pikkarainen M, Osman AA, Streichenberger N, Leisser I, Verchère J, Baron T, Alafuzoff I, Budka H, Perret-Liaudet A, Lachmann I (2012) An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology. Acta Neuropathol 124:37–50. https://doi.org/10.1007/s00401-012-0964-x

Article  CAS  PubMed  Google Scholar 

Nakamura K, Mori F, Kon T, Tanji K, Miki Y, Tomiyama M, Kurotaki H, Toyoshima Y, Kakita A, Takahashi H, Yamada M, Wakabayashi K (2016) Accumulation of phosphorylated α-synuclein in subpial and periventricular astrocytes in multiple system atrophy of long duration: phosphorylated α-synuclein in MSA astrocytes. Neuropathology 36:157–167. https://doi.org/10.1111/neup.12243

Article  CAS  PubMed  Google Scholar 

Song YJC, Halliday GM, Holton JL, Lashley T, O’Sullivan SS, McCann H, Lees AJ, Ozawa T, Williams DR, Lockhart PJ, Revesz TR (2009) Degeneration in different Parkinsonian syndromes relates to astrocyte type and astrocyte protein expression. J Neuropathol Exp Neurol 68:1073–1083. https://doi.org/10.1097/NEN.0b013e3181b66f1b

Article  CAS  PubMed  Google Scholar 

Sorrentino ZA, Goodwin MS, Riffe CJ, Dhillon J-KS, Xia Y, Gorion K-M, Vijayaraghavan N, McFarland KN, Golbe LI, Yachnis AT, Giasson BI (2019) Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression. Acta Neuropathol Commun 7:142. https://doi.org/10.1186/s40478-019-0787-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Terada S, Ishizu H, Haraguchi T, Takehisa Y, Tanabe Y, Kawai K, Kuroda S (2000) Tau-negative astrocytic star-like inclusions and coiled bodies in dementia with Lewy bodies. Acta Neuropathol 100:464–468. https://doi.org/10.1007/s004010000213

Article  CAS  PubMed  Google Scholar 

Fauvet B, Mbefo MK, Fares M-B, Desobry C, Michael S, Ardah MT, Tsika E, Coune P, Prudent M, Lion N, Eliezer D, Moore DJ, Schneider B, Aebischer P, El-Agnaf OM, Masliah E, Lashuel HA (2012) α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J Biol Chem 287:15345–15364. https://doi.org/10.1074/jbc.M111.318949

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burai R, Ait-Bouziad N, Chiki A, Lashuel HA (2015) Elucidating the role of site-specific nitration of α-synuclein in the pathogenesis of Parkinson’s disease via protein semisynthesis and mutagenesis. J Am Chem Soc 137:5041–5052. https://doi.org/10.1021/ja5131726

Article  CAS  PubMed  Google Scholar 

Dikiy I, Fauvet B, Jovičić A, Mahul-Mellier A-L, Desobry C, El-Turk F, Gitler AD, Lashuel HA, Eliezer D (2016) Semisynthetic and in vitro phosphorylation of alpha-synuclein at Y39 promotes functional partly helical membrane-bound states resembling those induced by PD mutations. ACS Chem Biol 11:2428–2437. https://doi.org/10.1021/acschembio.6b00539

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fauvet B, Butterfield SM, Fuks J, Brik A, Lashuel HA (2013) One-pot total chemical synthesis of human α-synuclein. Chem Commun 49:9254. https://doi.org/10.1039/c3cc45353g

Article  CAS  Google Scholar 

Kumar ST, Jagannath S, Francois C, Vanderstichele H, Stoops E, Lashuel HA (2020) How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology. Neurobiol Dis 146:105086. https://doi.org/10.1016/j.nbd.2020.105086

Article  CAS  PubMed  Google Scholar 

Altay MF, Kumar ST, Burtscher J, Jagannath S, Strand C, Miki Y, Parkkinen L, Holton JL, Lashuel HA (2022) Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases. bioRxiv 2022.05.26.493598

Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ, Barbour R, Huang J, Kling K, Lee M, Diep L, Keim PS, Shen X, Chataway T, Schlossmacher MG, Seubert P, Schenk D, Sinha S, Gai WP, Chilcote TJ (2006) Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281:29739–29752. https://doi.org/10.1074/jbc.M600933200

Article  CAS  PubMed  Google Scholar 

Cavey JR, Ralston SH, Hocking LJ, Sheppard PW, Ciani B, Searle MS, Layfield R (2004) Loss of ubiquitin-binding associated with Paget’s disease of bone p62 (SQSTM1) mutations. J Bone Miner Res 20:619–624. https://doi.org/10.1359/JBMR.041205

Article  CAS  PubMed  Google Scholar 

Lee Y, Weihl CC (2017) Regulation of SQSTM1/p62 via UBA domain ubiquitination and its role in disease. Autophagy 13:1615–1616. https://doi.org/10.1080/15548627.2017.1339845

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raasi S, Varadan R, Fushman D, Pickart CM (2005) Diverse polyubiquitin interaction properties of ubiquitin-associated domains. Nat Struct Mol Biol 12:708–714. https://doi.org/10.1038/nsmb962

Article  CAS  PubMed  Google Scholar 

Neumann M, Müller V, Kretzschmar HA, Haass C, Kahle PJ (2004) Regional distribution of proteinase K-resistant α-synuclein correlates with Lewy body disease stage. J Neuropathol Exp Neurol 63:1225–1235. https://doi.org/10.1093/jnen/63.12.1225

Article  CAS  PubMed  Google Scholar 

Tanji K, Mori F, Mimura J, Itoh K, Kakita A, Takahashi H, Wakabayashi K (2010) Proteinase K-resistant α-synuclein is deposited in presynapses in human Lewy body disease and A53T α-synuclein transgenic mice. Acta Neuropathol 120:145–154. https://doi.org/10.1007/s00401-010-0676-z

Article  CAS  PubMed  Google Scholar 

Vaikath NN, Majbour NK, Paleologou KE, Ardah MT, van Dam E, van de Berg WDJ, Forrest SL, Parkkinen L, Gai W-P, Hattori N, Takanashi M, Lee S-J, Mann DMA, Imai Y, Halliday GM, Li J-Y, El-Agnaf OMA (2015) Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology. Neurobiol Dis 79:81–99. https://doi.org/10.1016/j.nbd.2015.04.009

Article  CAS  PubMed  Google Scholar 

Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) α-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160–164. https://doi.org/10.1038/ncb748

Article  CAS  PubMed  Google Scholar 

Hasegawa M, Fujiwara H, Nonaka T, Wakabayashi K, Takahashi H, Lee VM-Y, Trojanowski JQ, Mann D, Iwatsubo T (2002) Phosphorylated α-synuclein is ubiquitinated in α-synucleinopathy lesions. J Biol Chem 277:49071–49076. https://doi.org/10.1074/jbc.M208046200

Article  CAS  PubMed  Google Scholar 

Bodles AM, Guthrie DJS, Harriott P, Campbell P, Irvine GB (2000) Toxicity of non-Aβ component of Alzheimer’s disease amyloid, and N-terminal fragments thereof, correlates to formation of β-sheet structure and fibrils: toxicity of non-Aβ component and fragments thereof. Eur J Biochem 267:2186–2194. https://doi.org/10.1046/j.1432-1327.2000.01219.x

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif